4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-044748
Chief Business Officer sold 11,110 shares at $47.65 ($529,404)
- Chief Business Officer acquired 11,110 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Parrish Jay Chief Business Officer | 2020-08-03 | Option exercise | +9,259 | $1.49 | $13,750 | 231,481 | D |
| Parrish Jay Chief Business Officer | 2020-08-03 | Option exercise | +1,851 | $1.58 | $2,915 | 233,332 | D |
| Parrish Jay Chief Business Officer | 2020-08-03 | Sale | −11,110 | $47.65 | $529,404 | 222,222 | D |
| Derivatives | |||||||
| Parrish Jay Chief Business Officer | 2020-08-03 | Option exercise · Stock Option (Right to Buy) | −9,259 | 37,037 | D | ||
| Parrish Jay Chief Business Officer | 2020-08-03 | Option exercise · Stock Option (Right to Buy) | −1,851 | 60,184 | D | ||
| Open-market sales · 11,110 sh · avg $47.65 · $529,404 | |||||||
Loading xslF345X03/doc4.xml…